Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Target ID: TTDC00205

Target Information
NameGlucagon-like peptide 1    
Type of targetSuccessful target    
Glucagon-like peptide-1(7-36)-amide    
DiseaseAlzheimer's disease
[ICD9: 331.0   ICD10: G30]
[ICD9: 278   ICD10: E66]
Drug(s)AVE0010Phase IIIT2 diabetes[3]
AlbiglutidePhase IIIType 2 diabetes[4]
CJC-1134-PCPhase IIType 2 diabetes
Lixisenatide + LantusPhase IIFixed-Ratio / Type 2 diabetes
RG7685Phase IIType 2 diabetes
2374697Phase IObesity
LixisenatideRegistrationType 2 diabetes
Lixisenatide + LantusPhase IFix-Flex / Type 2 diabetes
NN9926Phase IType 2 diabetes
RG7697Phase IType 2 diabetes
VRS-859Phase IType 2 diabetes
UniProt IDP41521
Target ValidationClick to Find Target Validation Information.    
Cross References 3D Structure
Related Literature
On-Line Medical Dictionary
Ref 1Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron. J Neurosci Res. 2003 Jun 1;72(5):603-12. To Reference
Ref 2Promising new approaches to the management of obesity. Drugs. 2000 Jul;60(1):1-9. To Reference
Ref 3Pharma & Vaccines. Product Development Pipeline. April 29 2009. To Reference
Ref 4GSK. Product Development Pipeline. February 2009. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543